ArticleMolecular biology reports2025
Development of a TaqMan based real-time PCR assay for the detection of bovine ephemeral fever virus.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vector-borne diseases-knowledge maps.EFSA journal. European Food Safety Authority · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBovine ephemeral fever (BEF) is a significant disease in nations such as India, where there is a large bovine population and environmental conditions which foster the proliferation of blood-feeding insects. Effective control and prevention of the disease necessitate early and precise detection of bovine ephemeral fever virus (BEFV), the causative agent of BEF. In the present study, a TaqMan real time PCR assay with high sensitivity and specificity was developed for accurate detection of BEFV. METHODS AND
resultsThe glycoprotein (G) gene of BEFV was targeted for the assay development. A positive construct of the G gene was developed by identifying the conserved regions through the alignment of the available G gene sequences from GenBank. The primers and probes had been designed in-house and synthesised commercially. The TaqMan probe-based assay was standardized using the gene construct as a positive control. The developed assay demonstrated an exceptional sensitivity for the detection and quantification of viral genomes, capable of identifying as few as 24 copies of the genome with a R² value of 0.9998 by standard curve analysis. The developed assay demonstrated a sensitivity that was 100 times greater than the conventional PCR method and showed remarkable efficiency for the BEFV detection using field blood samples from both suspected and healthy animals.
conclusionThe developed assay showed high sensitivity and specificity in clinical applicability analysis. This real-time PCR-based assay would offer a reliable and adaptable diagnostic tool for the rapid and precise identification of BEFV in disease diagnosis, research, and field surveillance applications.
Indexed as
Identifiers
41105329What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.